Literature DB >> 12553439

Body composition and nutritional parameters in HIV and AIDS patients.

Jérôme Salomon1, Pierre de Truchis, Jean-Claude Melchior.   

Abstract

Undernutrition is a frequent complication of evolutive and chronic HIV (human immunodeficiency virus) infection characterized by bodyweight loss and changes in body composition. The Centers for Disease Control and Prevention define AIDS wasting as involuntary loss of more than 10% of body weight, plus more than 30 days of either diarrhea, or weakness and fever. Wasting syndrome has been considered as a case definition of the AIDS disease since 1987. Wasting syndrome is clearly linked to disease progression and death. Despite the progress under the era of highly active antiretroviral therapy (HAART), wasting is still a problem for people with AIDS. A small part of the weight lost is fat. More important is the loss of "lean body mass", which is mostly muscle. Body composition changes during HIV infection are different from those observed in food deprivation. Under the era of HAART, a HIV-associated adipose redistribution syndrome (HARS) was described that associates subcutaneous lipoatrophy and abdominal obesity linked to various metabolic disorders. Several factors contribute to wasting syndrome. Not only low food intake and poor nutrient absorption, but mainly altered metabolism (increased resting energy expenditure) and specific disturbances in protein turnover, which is also increased. Nutritional evaluation of HIV-infected patients should include the measurement of body composition and analysis of nutritional parameters, including albumin, transthyretin and C-reactive protein. Transthyretin seems to be particularly useful to follow the recovery period of malnutrition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12553439     DOI: 10.1515/CCLM.2002.229

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  9 in total

1.  Effect of HIV infection on body composition and fat distribution in Rwandan women.

Authors:  Eugene Mutimura; Kathryn Anastos; Mardge Cohen; Agnes Binagwaho; Donald P Kotler
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2010 May-Jun

Review 2.  Neural Control of Energy Expenditure.

Authors:  Heike Münzberg; Emily Qualls-Creekmore; Hans-Rudolf Berthoud; Christopher D Morrison; Sangho Yu
Journal:  Handb Exp Pharmacol       Date:  2016

3.  Chronic kidney disease and estimates of kidney function in HIV infection: a cross-sectional study in the multicenter AIDS cohort study.

Authors:  Michelle M Estrella; Rulan S Parekh; Brad C Astor; Robert Bolan; Rhobert W Evans; Frank J Palella; Lisa P Jacobson
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-15       Impact factor: 3.731

4.  Availability of nutritional support services in HIV care and treatment sites in sub-Saharan African countries.

Authors:  Aranka Anema; Wendy Zhang; Yingfeng Wu; Batya Elul; Sheri D Weiser; Robert S Hogg; Julio S G Montaner; Wafaa El Sadr; Denis Nash
Journal:  Public Health Nutr       Date:  2011-08-02       Impact factor: 4.022

5.  Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.

Authors:  Julia H Arnsten; Ruth Freeman; Andrea A Howard; Michelle Floris-Moore; Yungtai Lo; Robert S Klein
Journal:  AIDS       Date:  2007-03-12       Impact factor: 4.177

6.  Validation of bioelectrical impedance analysis in Ethiopian adults with HIV.

Authors:  Maria H Hegelund; Jonathan C Wells; Tsinuel Girma; Daniel Faurholt-Jepsen; Dilnesaw Zerfu; Dirk L Christensen; Henrik Friis; Mette F Olsen
Journal:  J Nutr Sci       Date:  2017-12-18

7.  Release of Soluble Insulin Receptor From Neurons by Cerebrospinal Fluid From Patients With Neurocognitive Dysfunction and HIV Infection.

Authors:  Yamil Gerena; Raissa Menéndez-Delmestre; Andrea Delgado-Nieves; Joyce Vélez; Jarold Méndez-Álvarez; Javier E Sierra-Pagan; Richard L Skolasky; Lisa Henderson; Avindra Nath; Valerie Wojna
Journal:  Front Neurol       Date:  2019-03-26       Impact factor: 4.003

8.  Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV- and tuberculosis-infected South African patients.

Authors:  Doaa Elsherbiny; Karen Cohen; Britt Jansson; Peter Smith; Helen McIlleron; Ulrika S H Simonsson
Journal:  Eur J Clin Pharmacol       Date:  2008-08-27       Impact factor: 3.064

Review 9.  Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms.

Authors:  Johanna M Gostner; Kathrin Becker; Katharina Kurz; Dietmar Fuchs
Journal:  Front Psychiatry       Date:  2015-07-14       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.